Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Oncology Reports|October 14, 2011
Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemiaJie Li, Liying Xue, Hongling Hao, et al.
Brain Research Bulletin|November 14, 2025
The NLRP3 inflammasome in depression: A narrative review from neuroinflammation to novel therapeutic approachesLinwei Ding, Liying Xue, Canyu Cheng, et al.
Frontiers in Oncology|May 15, 2026
Efficacy and safety of CD38-directed CAR-T cell therapy for multiple myeloma: a systematic review and meta-analysisXinlong Xu, Chang Dong, Jiashuo Guo, et al.
Cancer Management and Research|May 3, 2022
CMTM Family and Gastrointestinal Tract Cancers: A Comprehensive ReviewJie Li, Xiaozi Wang, Xiaoning Wang, et al.
Molecular and Cellular Biochemistry|August 11, 2017
DIAPH3 promoted the growth, migration and metastasis of hepatocellular carcinoma cells by activating beta-catenin/TCF signalingLi Dong, Zhijun Li, Liying Xue, et al.
Cancer Biomarkers : Section a of Disease Markers|February 18, 2017
Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinomaLiying Xue, Jinglong Nan, Li Dong, et al.
Molecular Medicine Reports|July 5, 2021
Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cellsJie Li, Xiaozi Wang, Chuanbao Ma, et al.
Pageof 5